NEWLY DIAGNOSED GLIOBLASTOMA
Clinical trials for NEWLY DIAGNOSED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves unlock Brain's defenses against deadly tumor
Disease control Recruiting nowThis study tests a new approach for people with a recently diagnosed aggressive brain cancer called glioblastoma. A device with 9 ultrasound emitters is implanted in the skull to temporarily open the blood-brain barrier, allowing immune-boosting drugs to reach the tumor more effe…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New vaccine aims to train the immune system to fight deadly brain cancer
Disease control Recruiting nowThis study tests a new vaccine designed to help the immune system recognize and attack glioblastoma, an aggressive brain cancer. About 35 adults who have already had surgery and standard chemoradiation will receive the vaccine. The goal is to see if it is safe and whether it trig…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New gene therapy fights deadly brain tumors with a One-Two punch
Disease control Recruiting nowThis trial tests a new gene therapy called TGX-007 for people with a fast-growing brain cancer called glioblastoma. The therapy uses a harmless virus to deliver two special instructions: one helps a common drug kill cancer cells, and the other wakes up the immune system to attack…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Trogenix ltd • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Immunotherapy duo takes on deadliest brain cancer
Disease control Recruiting nowThis study tests whether adding two immunotherapy drugs (nivolumab and relatlimab) to standard treatment can help the immune system fight glioblastoma, an aggressive brain cancer. About 92 adults with newly diagnosed glioblastoma will receive these drugs before and after surgery.…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for aggressive brain cancer: combo therapy enters phase 2 trial
Disease control Recruiting nowThis study tests whether adding silevertinib (an oral targeted therapy) to standard chemotherapy (temozolomide) helps people with a specific type of newly diagnosed glioblastoma live longer without their cancer growing. About 162 adults whose tumors have certain genetic markers (…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:54 UTC